Scientists and drug companies are racing to develop and test treatments and vaccines that address COVID-19, the disease caused by the novel coronavirus. Work on both is progressing at an unprecedented speed — but researchers are starting essentially from scratch on vaccine development, so the process is going to take a long time. Treatments, on the other hand, were further along when the outbreak started and might be available sooner.
"They're in vastly different situations right now," says Florian Krammer, a professor and vaccine development expert at the Icahn School of Medicine at Mount Sinai.
Both treatments and vaccines are important for a robust and effective response to the outbreak. Treatments help people after they already have a disease; in the case of COVID-19, researchers hope to treat the around 15 percent of COVID-19 patients who have non-mild symptoms. Vaccines, on the other hand, help prevent people from getting sick in the first place.
Scientists started work on drugs to treat coronaviruses during the SARS and MERS outbreaks, but because the outbreaks died down, the job was never completed. Now, they're able to dust off that old research and start building on it. The leading candidate is a drug called remdesivir , which was developed by the pharmaceutical company Gilead. Research showed that it could block SARS and MERS in cells and in mice. In addition, remdesivir was used in a clinical trial looking for treatments for Ebola — and therefore, it had already gone through safety testing to make sure it doesn't cause any harm.
That's why teams in China and the US were able to start clinical trials testing remdesivir in COVID-19 patients so quickly . There should be data available showing if it helps them get better as soon as April. If it proves effective, Gilead would presumably be able to ramp up production and get the drug in the hands of doctors fairly quickly, Krammer says.
The vaccine development process will take much longer. Experts say that it will be between a year and 18 months, or maybe longer, before they're available to the public. One of the strategies for creating a vaccine involves making copies of one part of the virus ( in this case , the bit that the novel coronavirus uses to infiltrate cells). Then, the immune system of the person who receives the vaccine makes antibodies that neutralize that particular bit. If they were exposed to the virus, those antibodies would be able to stop the virus from functioning.
The pharmaceutical company Moderna is the furthest along in the process; it already has that type of vaccine ready for testing . A trial in 45 healthy people to make sure that it's safe will start in March or April and will take around three months to complete. After that, it'll have to be tested in an even larger group to check if it actually immunizes people against the novel coronavirus. That will take six to eight months. And then, it'll have to be manufactured at a huge scale, which poses an additional challenge.
Making vaccines is always challenging. Developing this one is made more difficult because there has never been a vaccine for any type of coronavirus. "We don't have a production platform, we have no experience in safety, we don't know if there will be complications. We have to start from scratch, basically," Krammer says.
It was much easier to make a vaccine for H1N1, known as swine flu, which emerged as a never-before-seen virus in 2009. "There are large vaccine producers in the US and globally for flu," Krammer says. Manufacturers were able to stop making the vaccine against the seasonal flu and start making a vaccine for this new strain of flu. "They didn't need clinical trials, they just had to make the vaccine and distribute it," he says.
There won't be a vaccine done in time to hold off any approaching outbreak of COVID-19 in the US or in other countries where it's still not widespread. That's why treatments are so important: along with good public health practices, they can help blunt the impact of the disease and make it less of an unstoppable threat. The best experts can hope for is that a vaccine can help prevent other outbreaks in the future if the novel coronavirus sticks around.
- Hospitals in England 'on track' to have more than 20,000 Covid patients needing treatment on New Year's Eve as experts warn second wave pressure on NHS is 'on course' to exceed darkest part of the spring within days
- Record 3,700 people die in a single day from COVID as new high of 124,000 are hospitalized as mutant strain is found in Colorado
- Britain's mass vaccination drive will start TUESDAY: NHS boss says race to beat Covid will begin on Dec 8 with UK set to get 'MILLIONS' of doses of Pfizer's jab before New Year amid fears first batch of 800,000 'could be all we get for some time'
- 'Britain joined the vaccine marathon in the last mile': Now US's top doctor Fauci accuses UK regulator of not properly scrutinising data before rushing approval through - as bitter EU tells Gavin Williamson to stop gloating 'as if it is a football game'
- Janice Dean: The tragic rise of Andrew Cuomo amid COVID-19 -- a real American crisis
- Vaccine drive FINALLY starts accelerating - but will it be enough to end lockdown before March? Approval time for doses is cut from twenty days to to five as GPs start CANCELLING jabs because doses have not been delivered
- COVID-19: Businesses revising outlooks not just concentrating on repairing balance sheets
- Queen launches Britain's jab blitz: Vaccine superhubs get ready to inject four people a minute and Matt Hancock unveils a mass rapid testing drive to curb the tide against the virus as it claims another 1,035 lives
- Hopes all over-50s can be vaccinated by spring to save UK from hell of surging second wave – as NHS chief says medics are 'in the eye of the storm' and hospitalisations and cases pass first-wave peaks
- The Spot: The politics of Colorado’s vaccine plan, GOP seeks election probes and Gardner’s farewell
- COVID doctor relives heartbreaking moment pensioner died on the phone to his wife: Medic reveals how he believed patient was 'on road to recovery' - only to return 15 minutes later to find him dead, cradling his mobile
- Critically-ill Covid patients in London and south east will be sent to hospitals in the West Country to ease pressure on overwhelmed wards amid second wave as medics warn of more under 30s battling virus in intensive care
It’s going to take a lot longer to make a COVID-19 vaccine than a treatment have 1113 words, post on www.theverge.com at February 28, 2020. This is cached page on VietNam Breaking News. If you want remove this page, please contact us.